Showing results (181-190 of 575) with videos related to
Sort By:
Pageof 58
Handbook of Clinical Neurology|October 11, 2016
Psychogenic (functional) parkinsonismM A Thenganatt, J JankovicNeurology|June 20, 1998
Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical responseP A Hanna, J JankovicMovement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Speech dysfluency exacerbated by levodopa in Parkinson's diseaseE D Louis, L Winfield, S Fahn, et al.Advances in Neurology|January 1, 1986
Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortexH R Wagner, A Reches, E Yablonskaya, et al.Clinical Neuropharmacology|October 5, 2001
Choosing dopamine agonists in Parkinson's diseaseE K Tan, J JankovicDrugs & Aging|June 23, 2001
Are dopamine receptor agonists neuroprotective in Parkinson's disease?W D Le, J JankovicNeurology|April 1, 1993
Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystoniaJ Jankovic, K S SchwartzMovement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Cocaine-related movement disordersF E Cardoso, J JankovicMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Sulpiride-induced tardive dystoniaL G Miller, J JankovicPageof 58